Answers are grounded in this paper and cite their sources.
Observational analysis shows cfDNA fragmentomic profiling accurately distinguishes malignant from benign colorectal lesions, suggesting improved diagnostics.
This study demonstrates that cfDNA fragmentomic profiling, particularly differential patterns of Alu and LTR elements, effectively discriminates benign from malignant colorectal lesions. These findings validate the clinical utility of repetitive element analysis and provide a foundation for developing improved non-invasive CRC diagnostics through machine learning approaches incorporating genomic features.
No takes yet. Share an insight, caveat, or question.
Shan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: